ResearcherOntario Institute for Cancer ResearchNo recent work listed
Stefano Serra
Matched on ORCID iD 0000-0002-3258-2637; OpenAlex author ID A5067895208. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 41
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 9
- Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR. Last author DOI 10.1016/j.labinv.2023.100145↗
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Co-author DOI 10.1016/j.ccell.2018.12.010↗
- Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2016.3916↗
- Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study. First author DOI 10.1136/jclinpath-2016-203947↗
- Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. First author DOI 10.1038/bjc.2015.284↗
- Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/pas.0000000000000333↗
- Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0289↗
- Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer. Co-author DOI 10.1186/1479-7364-7-11↗
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
Closest collaborators
The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Runjan Chetty · 2 shared papers, 2017–2023 · strength 0.24
- Steve Gallinger · 4 shared papers, 2013–2019 · strength 0.19
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimida… DOI 10.1038/bjc.2015.284↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Neesha C. Dhani · 3 shared papers, 2015–2017 · strength 0.17
- Paper Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study. DOI 10.1136/jclinpath-2016-203947↗
- Paper Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimida… DOI 10.1038/bjc.2015.284↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Daniel Xia · 1 shared paper, 2023 · strength 0.16
- David William Hedley · 3 shared papers, 2015–2019 · strength 0.15
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimida… DOI 10.1038/bjc.2015.284↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Robert C. Grant · 3 shared papers, 2013–2019 · strength 0.13
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Paper Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer. DOI 10.1186/1479-7364-7-11↗
- Sangeetha N. Kalimuthu · 2 shared papers, 2017 · strength 0.12
- Sean Patrick Cleary · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Ashton Anthony Connor · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Michelle Chan‐Seng‐Yue · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Sarah P. Thayer · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Michael Anthony Hollingsworth · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Michael H. A. Roehrl · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Gloria M. Petersen · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Faiyaz Notta · 2 shared papers, 2017–2019 · strength 0.10
- Paper Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Me… DOI 10.1016/j.ccell.2018.12.010↗
- Paper Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenoca… DOI 10.1001/jamaoncol.2016.3916↗
- Ayelet Borgida · 2 shared papers, 2013–2019 · strength 0.09
- Talia Golan · 1 shared paper, 2019 · strength 0.06
- Sandra Elisabeth Fischer · 1 shared paper, 2019 · strength 0.06
- Joan Miguel Romero · 1 shared paper, 2019 · strength 0.06
- Alyssa L. Smith · 1 shared paper, 2019 · strength 0.06
- Grainne Mary O'Kane · 1 shared paper, 2019 · strength 0.06
- Jennifer Jane Knox · 1 shared paper, 2019 · strength 0.06
- George Zogopoulos · 1 shared paper, 2019 · strength 0.06
- Alison Chan · 1 shared paper, 2014 · strength 0.05
- Eleftherios P. Diamandis · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.